In 1987, fewer than one in five American adults were obese, and by 1999, obesity was responsible for more than 300,000 excess ...

Ozempic could help patients with advanced Alzheimer’s disease, scientists believe. Trials are underway examining the impact ...

The average person taking Ozempic loses about 15 pounds after three months and 27 pounds after six months. But now it seems ...

The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...

Users on TikTok have touted the benefits of taking berberine supplements, claiming benefits for weight loss, heart health and ...

PERSPECTIVES: The resurgence of Y2K skin-baring fashion trends coincides with the rise of prescription weight loss drugs like ...

Tiny doses of the weight-loss drug can sidestep its unpleasant side effects, say influencers. But is customising the dose a ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...

GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, ...

Two clinical trials investigating semaglutide (Ozempic, Wegovy) as an early Alzheimer's treatment are expected to wrap up in ...

And Alcon Laboratories issued a voluntary nationwide recall of certain Systane Lubricant Eye Drops due to fungal ...

Independence Blue Cross said starting Jan. 1 it will only be covering GLP-1 agonists — commonly sold under brand names like ...